The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efficacy and safety of MCLA-129, an EGFR/c-MET bispecific antibody, in advanced non-small cell lung cancer (NSCLC).
 
Jie Wang
No Relationships to Disclose
 
Jia Zhong
No Relationships to Disclose
 
Lin Wu
Speakers' Bureau - AstraZeneca; Bristol-Myers Squibb; Hengrui Medicine; Innovate Biopharmaceuticals; Lilly; MSD; Pfizer; Roche China
 
Bolin Chen
No Relationships to Disclose
 
Zhe-Hai Wang
Consulting or Advisory Role - Hansoh Pharma
Research Funding - Hansoh Pharma (Inst)
 
Yu Yao
No Relationships to Disclose
 
Xiaorong Dong
No Relationships to Disclose
 
Wei Li
No Relationships to Disclose
 
Xiubao Ren
No Relationships to Disclose
 
Xiaoming Hou
No Relationships to Disclose
 
Ai-min Zang
No Relationships to Disclose
 
Xiujuan Qu
No Relationships to Disclose
 
Guojun Zhang
No Relationships to Disclose
 
Yongsheng Wang
No Relationships to Disclose
 
Yuansong Bai
No Relationships to Disclose
 
Linlin Liu
No Relationships to Disclose
 
Guohua Yu
No Relationships to Disclose
 
Xingwu Chen
No Relationships to Disclose
 
Lieming Ding
Employment - Betta Pharmaceuticals
Leadership - Betta Pharmaceuticals
Stock and Other Ownership Interests - Betta Pharmaceuticals
Honoraria - Betta Pharmaceuticals
Patents, Royalties, Other Intellectual Property - Betta Pharmaceuticals